DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PH-797804 is an investigational drug.
There have been 14 clinical trials for PH-797804. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Lung Diseases, Obstructive, Lung Diseases, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PH-797804
|A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804||Pfizer||Phase 1|
|A Study to Investigate the Effect of PH-797804 on QTc Interval||Pfizer||Phase 1|
|A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804||Pfizer||Phase 1|